sST2 and Cardiac Surgery

Completed

• Conditions: Cardiac Surgery

• Registration Number: NCT03887767
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Evaluation of the prognosis value of sST2 dosed before cardiac surgery on prognosis of long terme prognosis after cardiac surgery.

The patients where initialy recruted for another cohort named micro-SIRS and inflammation but the gaved their consent to analyse the blood samples for other studies

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-03-05
• Study First Submitted QC: 2019-03-21
• Study Start: 2019-03-25
• Study First Posted: 2019-03-25
• Primary Completion: 2019-12-01
• Study Completion: 2019-12-20
• Status Verified: 2020-03
• Last Update Submitted: 2020-03-09
• Last Update Posted: 2020-03-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 158

Inclusion Criteria

• Age between 18 and 80
• cardiac surgery includind coronary arterial bypass of valvular surgery

Exclusion Criteria

• other surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality rate	1 year	1 year mortality rate

Secondary Outcome Measures

Name	Time	Method
Number of cardiac events	1 day	Number of cardiac events
Number of cardiac stroke	1 day	Number of cardiac stroke
Number of rehospitalisation	1 day	Number of rehospitalisation

Trial Locations

Locations (1)

Uhmontpellier; 🇫🇷 Montpellier, France